Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct site in the gastrontestinal tract are two of them....

Product Specialist at Gradientech AB, Uppsala

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Nervceller för mod och risktagande funna

Varför tar vissa människor utan att tveka risker som andra människor aldrig någonsin skulle göra? I en ny studie har forskare funnit att en viss typ av celler i...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

VD:n om att bygga världsföretag: ”Utveckla inte läkemedel för Nobelpris”

För att bygga ett medicinskt företag i världsklass krävs fyra grundelement, enligt Ascelia Pharmas vd Magnus Corfitzen. – Tre av dem blir ni inte överraskade av...

Bioventure hub blir dubbelt så stort

Life science-företagsparken i Astrazenecas lokaler i Mölndal fördubblar sin yta.

Drug development creates new challenges for regulators

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

”Sverige klarar tillverkningen”

I Matfors bygger Cobra Biologics två unika tillverkningssviter för storskalig GMP-tillverkning av ATMP-produkter. Kontraktstillverkaren rustar för att möta den ...

Axlade tunga uppdraget – nu prisas vaccinkändisen Richard Bergström

Pandemin var i full gång, och ingen visste när eller ens om ett vaccin skulle komma. I det läget ringde socialministern med ett förslag – och Richard Bergström ...

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

9 steps to perfect partnering

Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...

Astrazeneca varslar i Indien

Stänger site och flyttar forskningen.

Forskningsproppen: SwedenBios tredje förslag

Möjliggör för fler företagsinitierade kliniska prövningar - så lyder SwedenBios tredje förslag till regeringen inför forskningsproppen nästa höst.

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm

Hallå där Mats Nilsson…

…ny site-chef på Scilifelab i Stockholm. Vad ska du göra?

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

Sobi flyttar tillverkning till Pfizer

Sobi flyttar tillverkning från Österrike till Pfizers anläggning i Strängnäs.